Literature DB >> 24940111

Kissing and hpv: honest popular visions, the human papilloma virus, and cancers.

L Z G Touyz.   

Abstract

Entities:  

Year:  2014        PMID： 24940111      PMCID： PMC4059815          DOI： 10.3747/co.21.1970

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  7 in total

Review 1.  Sexually transmissible infections other than HIV.

Authors:  Basil Donovan
Journal:  Lancet       Date:  2004-02-14       Impact factor: 79.321

2.  Incidence, age at onset, and potential reasons of malignant transformation in recurrent respiratory papillomatosis patients: 20 years experience.

Authors:  Valentin Gerein; Eugen Rastorguev; Johann Gerein; Wolfgang Draf; Joachim Schirren
Journal:  Otolaryngol Head Neck Surg       Date:  2005-03       Impact factor: 3.497

3.  2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.

Authors:  L Stewart Massad; Mark H Einstein; Warner K Huh; Hormuzd A Katki; Walter K Kinney; Mark Schiffman; Diane Solomon; Nicolas Wentzensen; Herschel W Lawson
Journal:  Obstet Gynecol       Date:  2013-04       Impact factor: 7.661

4.  A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis.

Authors:  Dorothy H Crawford; Karen F Macsween; Craig D Higgins; Ranjit Thomas; Karen McAulay; Hilary Williams; Nadine Harrison; Stuart Reid; Margaret Conacher; Jill Douglas; Anthony J Swerdlow
Journal:  Clin Infect Dis       Date:  2006-06-20       Impact factor: 9.079

Review 5.  The natural history of human papillomavirus infections of the mucosal epithelia.

Authors:  Louise T Chow; Thomas R Broker; Bettie M Steinberg
Journal:  APMIS       Date:  2010-06       Impact factor: 3.205

Review 6.  Human papillomavirus and disease mechanisms: relevance to oral and cervical cancers.

Authors:  S Nair; M R Pillai
Journal:  Oral Dis       Date:  2005-11       Impact factor: 3.511

7.  Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials.

Authors:  Elmar A Joura; Sepp Leodolter; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonzalo Perez; Laura A Koutsky; Suzanne M Garland; Diane M Harper; Grace W K Tang; Daron G Ferris; Marc Steben; Ronald W Jones; Janine Bryan; Frank J Taddeo; Oliver M Bautista; Mark T Esser; Heather L Sings; Micki Nelson; John W Boslego; Carlos Sattler; Eliav Barr; Jorma Paavonen
Journal:  Lancet       Date:  2007-05-19       Impact factor: 79.321
  7 in total
  1 in total

1.  Morbidity, mortality and cost from HPV-related oropharyngeal cancer: Impact of 2-, 4- and 9-valent vaccines.

Authors:  Greg Ward; Vikas Mehta; Michael Moore
Journal:  Hum Vaccin Immunother       Date:  2015-11-13       Impact factor: 3.452
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.